COVID-19 testing solutions

 

We offer various testing solutions that are used across the world today to support fast and trustworthy diagnosis:

  • qualitative molecular rapid detection kit based on real-time fluorescent reverse transcription isothermal amplification and testing of naso- or oropharyngeal swab samples. This assay gives results within 75 minutes and does not require RNA extraction.
  • high-sensitive antigen assay running on our fully automated chemiluminescent platform, capable of testing both nasopharyngeal swab fluid or saliva samples and giving fast results, in up to 25 minutes.
  • lateral flow-based rapid antigen test that does not require any special equipment. This portable single assay device evaluates nasopharyngeal swab fluid, it uses a simple procedure and has a short time to result, of only 30 minutes.

Furthermore, thanks to our long-lasting and extensive experience in lung disease testing we also offer associated testing solutions that allow to predict disease severity in patients infected with SARS-CoV-2. 

Read more below or contact us today
 

Insights

Webinar: Lumipulse® G KL-6, the biomarker for routinely assessment of epithelial alveolar damage in pulmonary fibrosis and COVID-19

Oct 19, 2020

During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University Hospital, Essen, Germany), Dr. Elena Bargagli (MD - Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, Siena University Hospital, Siena, Italy), ...

Read more